Dr. Sznol Discusses the Role of Surgery in Melanoma

Mario Sznol, MD
Published: Friday, Dec 08, 2017



Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the role of surgery in the treatment of patients with melanoma.

The role of surgery in melanoma is not going away, says Sznol. Even with the effective systemic therapies in place for this disease, sometimes surgery is warranted and can lead to a longer survival.

Although several patients in the metastatic setting tend to benefit from immunotherapy, some patients will not achieve a complete response and lesions will remain. If those lesions are resected, some patients remain progression-free for a long period of time.
 
SELECTED
LANGUAGE


Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the role of surgery in the treatment of patients with melanoma.

The role of surgery in melanoma is not going away, says Sznol. Even with the effective systemic therapies in place for this disease, sometimes surgery is warranted and can lead to a longer survival.

Although several patients in the metastatic setting tend to benefit from immunotherapy, some patients will not achieve a complete response and lesions will remain. If those lesions are resected, some patients remain progression-free for a long period of time.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Medical Crossfire®: What Does Data Tell Us About How to Optimize Checkpoint Inhibitor Strategies Across Lines of Care for Patients with Melanoma?Nov 30, 20191.5
Publication Bottom Border
Border Publication
x